Physician profile
Ryan Dalisky
NPI 1568727857
$1,479.98
in general payments reported to CMS, 2019-2025
18 companies · $78.01 in 2025
The $78.01 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.54 · 2020: $109 · 2021: $760 · 2022: $332 · 2023: $139 · 2024: $14.84 · 2025: $78.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $381.25 | 2020-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $175.21 | 2022-2023 | Signia |
| Boston Scientific Corporation | $148.94 | 2021-2022 | |
| Acera Surgical, INC. | $137.67 | 2020-2022 | |
| Conmed Corporation | $117.23 | 2021 | |
| Abbvie INC. | $92.85 | 2024-2025 | |
| Smith+Nephew, INC. | $76.52 | 2021-2022 | |
| Kls-Martin L.P. | $65.26 | 2021 | |
| Davol INC. | $61.16 | 2021-2022 | |
| Organogenesis INC. | $59.97 | 2023 | Puraply |
| Kowa Pharmaceuticals America, INC. | $42.33 | 2022-2023 | Seglentis |
| Biom'Up France Sas | $23.50 | 2020 | |
| Misonix INC | $22.87 | 2020 | |
| Abbott Laboratories | $21.01 | 2019 | |
| Olympus America INC. | $15.80 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $15.07 | 2019 | |
| Allergan, INC. | $11.88 | 2022 | |
| Covidien Lp | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Dalisky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.